Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
309M
-
Number of holders
-
194
-
Total 13F shares, excl. options
-
221M
-
Shares change
-
+2.89M
-
Total reported value, excl. options
-
$3.46B
-
Value change
-
+$48.7M
-
Put/Call ratio
-
0.13
-
Number of buys
-
95
-
Number of sells
-
-95
-
Price
-
$15.62
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q2 2018
259 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share as of Q2 2018.
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) has 194 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 221M shares
of 309M outstanding shares and own 71.66% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (20M shares), VANGUARD GROUP INC (16.3M shares), BlackRock Inc. (16M shares), FMR LLC (13.5M shares), Redmile Group, LLC (10.5M shares), JENNISON ASSOCIATES LLC (10.1M shares), venBio Select Advisor LLC (9.37M shares), JANUS HENDERSON GROUP PLC (8.18M shares), WELLINGTON MANAGEMENT GROUP LLP (8.1M shares), and STATE STREET CORP (7.96M shares).
This table shows the top 194 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.